Joseph Giangola from Hackensack University Medical Center: Making Strides In Treating Type 1 Diabetes

Video

While the number of treatments for type 1 diabetes lags behind those for type 2 there is still a lot of work being done to help these patients thanks in large part to technological advances.

%jwplayer%

While the number of treatments for type 1 diabetes lags behind those for type 2 there is still a lot of work being done to help these patients thanks in large part to technological advances.

Joseph Giangola, MD, from Hackensack University Medical Center, now known as HackensackUMC, discussed both current and future treatments during an interview with MD Magazine. One of the most promising developments in the pipeline, according to Giangola, is the artificial pancreas which could prove to be an invaluable tool for these patients much like the insulin pump has become for patients with type 2 diabetes.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
© 2024 MJH Life Sciences

All rights reserved.